Understanding DNA changes in cancer

Investigation of human DNA polymerase epsilon variants

NIH-funded research Tulane University of Louisiana · NIH-11119022

This work explores how certain DNA changes, especially in genes like BRCA2, contribute to the development of highly mutated cancers.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTulane University of Louisiana NIH-funded
Lab location1 site (New Orleans, United States)
Project IDNIH-11119022 on NIH RePORTER

What this research studies

We want to understand why some cancers have many DNA changes and how cells fail to protect themselves from these changes. Our focus is on specific DNA replication enzymes called POLE, which are often mutated in highly aggressive tumors. We believe that problems with POLE, combined with issues in other DNA repair genes like BRCA2, lead to unstable DNA and cancer growth. By studying these mechanisms, we hope to uncover new ways to fight these challenging cancers.

Who could benefit from this research

Good fit: This foundational research is most relevant to patients with cancers characterized by specific DNA polymerase mutations or those with BRCA2 mutations, as it aims to understand the underlying biology of their disease.

Not a fit: Patients whose cancers do not involve these specific DNA polymerase mutations or related DNA repair pathway issues may not directly benefit from this particular line of research.

Why it matters

Potential benefit: If successful, this work could lead to a deeper understanding of how certain cancers develop, potentially guiding the creation of new treatments for patients with highly mutated tumors, including those with BRCA2 mutations.

How similar studies have performed: This project builds upon the researchers' own published work and preliminary data, suggesting a foundation of prior findings in this area.

Where this research is happening

New Orleans, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Breast Cancer 2 GeneBreast Cancer Type 2 Susceptibility Gene
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.